Zacks Investment Research on MSN1d
Are Investors Undervaluing Invivyd, Inc. (IVVD) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025
We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
Invivyd Shares Down as Regulators Decline Expanded Use for Covid-19 Treatment
The commercial-stage biopharmaceutical company said its request to expand the existing emergency use authorization of the drug, also called pemivibart, to treat mild-to-moderate Covid-19 in more ...
Nasdaq8d
Invivyd, Inc. Reports Positive In Vitro Neutralization Data for PEMGARDA™ Against Dominant SARS-CoV-2 Variant LP.8.1
Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS ...
Invivyd (NASDAQ:IVVD) Earns “Buy” Rating from HC Wainwright
Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They currently have a $10.00 ...
Business Insider8d
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
March 05, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA™ (pemivibart) against the currently ...
Yahoo Finance6d
Invivyd, Inc. (IVVD)
2; affirms structural biology within Invivyd’s unique technology and reflects consi Invivyd (NasdaqGM:IVVD) has seen its share price surge by an impressive 163% over the past month, driven ...
Invivyd announces in vitro neutralization data for PEMGARDA
Invivyd (IVVD) announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA against the currently dominant ...
Benzinga.com17d
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
FDA rejected Invivyd’s request to expand Pemgarda's EUA for treating mild-to-moderate COVID-19 in immunocompromised patients. Invivyd plans to share detailed data on pemivibart, VYD2311 ...
ETF Daily News6d
Invivyd (NASDAQ:IVVD) Given Buy Rating at D. Boral Capital
Invivyd has a 1-year low of $0.35 and a 1-year high of $4.74. Insiders Place Their Bets In other Invivyd news, Director Terrance Mcguire sold 150,000 shares of Invivyd stock in a transaction that ...
Insider Monkey23d
Why Invivyd, Inc. (IVVD) Is Soaring This Year So Far
In this article, we are going to take a look at where Invivyd, Inc. (NASDAQ:IVVD) stands against the other micro and small-cap stocks. Nine micro-cap companies and one small-cap firm have been the ...
Yahoo Finance11d
Invivyd, Inc. (IVVD)
Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual ...